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  CLINICAL EVALUATION ON THE ・EFFECTIVENESS
OF CERNILTON－G） ON BENIGN PROSTATIC， HYPERTROPHY
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          Eisuke FuJiwARA and Motohiro FuJii
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  Twenty－one patients with benigri prostatic hypertrophy were treated with administration
of（】ern旦ton⑪ （cernitin），6tabl『ts per day for three皿Qnths・
The results were as follows．
i． Subjective effectiveness was observed in the improvement of night frequency （77．8％），
 sense of residual urine （52．9600）， forceless urinary stream （50．0％） and prolonged voiding
 time （46．7rde ）．
2． An overall subjective effectiveness was 66． 7ee（ of patients．
3． Cernilton＠ seems having no effect in prostatic size on rectal paipation， urethrocystography
 and Prostatic Weight on prostatornetry with ultrasound tomography．
4． ’Cernilton＠ is tend to improve the urine flow on uroflowmetry．
5． An overail objective effectiveness was not observed，
6． Hematological and blood chemistry examination showed no alteration due to administra－
 tion of aernilton＠．
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Table 1．Scoring for evaluation of
subjective symptoms．



















































Table 2： Scoring for evaluation of









improved 一1No changed O
Aggravated 十1
1mproved 一1No changed O
Aggravated   十1
Decreased 一1No changed O














































Table 3． Changes in subjective symptoms before and after the treatment period．
Case Age Nocturia Delay ot Prolonged
No， starting time veiding time     B  A B   A B   A
Forceiess
urinary stream
 B   A
Stralning Sense of
on urination residual urine























































































































































































































































B・1 Before， 一A ：一After一
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Table 4． Changes，in urodynamic data before and after the treatment period．
Case
No，
Maximu rn ． flow
rate （ml／sec）
 B    A
Average flow
rate （ml／sec）



















































































































































































































































B ： Befo re， A ： After，
Table 5．Prostatic weight before and
after the treatment period．




















































Table 8．Changes in objective signs before
and after the’ treatment・period．
Case Maximum flow






B ： Before， A ： After
Table 6．Changes of prostatic size on rectal
palpation by the treatment．
Size of























































































































Table 9． Laboratory data before and after treatment with Cernilton in patients with BPH．
Case RBC WBC
No， （×104）





（9 ） （× lo4）
B  A B  A
GOT GPT A［一P BUN Scr（U） （U） （U） （mgfdD （mg／dDBA BA B A BA BA
1  5ユ7 526  ユ14002 4363 452 46004 421 444 7000
5 427 468 5500
6 517 512 71007 4728 440 435 4600
9 451 464 860010 536 650011 410 460012 472 480 6100
13 514 532 6900
14 438 427 6800
15 403 408 6200
！5 472 468 780017 501 537 8900
18 488 507 5600
19 506 498’ 590020 395 402 5800
21 465 433 6100
09 0 15，3 15．8 44，8 44．8 23，0 18．4




















































































5 2322 22 17 13
24 1234 30 10 41
29 30 11 29







15 18 12 15 56 60  5 5 8032 2922    8
31 30 22 20
26 24 ！4 14
35 32 28 26
32 30 28 27
19 18 8 7
26 24 12 10
！3 18 ！9 20
66 72 81 78
28 30 22 20
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Table 10． Correlation between duration 6f
      urinary symptoms and subjective
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半able 11． Correlation between degree of
     prostatic enlargement and sub－
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